In an industry sector faced with globalisation, intense competition, and strict regulatory guidelines, Engenda have over 20 years experience in pharmaceutical industry project delivery. Our clients range from primary and secondary pharmaceutical manufacturing through to specialist equipment manufacturers and medical device specialists. We work with GMP production sites, research facilities and complete life sciences campus style sites.
With a detailed regulatory knowledge and understanding of industry relevant safety standards Engenda can deliver services of an exceptionally high-quality standard and safety performance. Offering full mechanical, electrical and instrumentation support services throughout the life of your project - from project management, design, fabrication and manufacture through to installation, test, commissioning and maintenance.
This include manufacturers of sterile salts, corticosteroids, Opiate alkaloids, Denatonium, biologics, bio-conjugates and various other medical applications to support the global pharmaceutical industry.
We have EPC, Design and Build and full turnkey experience with a large number of specialist equipment including: fast fill lines, finishing units, GMP production, Agitators, cappers, blister packers, bulk storage, blowers, boilers and many more. This includes new build, first installations or relocations of complete production units.
The global pharmaceutical market has experienced significant growth in recent years. As of end-2020, the total global pharmaceutical market was valued at about 1.27 trillion U.S. dollars. This is a significant increase from 2001 when the market was valued at just 390 billion U.S. dollars. Medicines and vaccines have helped deliver incredible improvements in health. When we invest in science and adopt and use new medicines we can eradicate disease and improve health outcomes.
The UK pharmaceutical sector employs approximately 63,000 people and generates a market value of around £21bn. With investment from leading companies, a strong network of science parks and a plethora or starts up with great potential; the UK pharmaceutical sector value is forecasted to increase by 19.3% to £25bn before 2023.
Services provided to the wider chemical and process industry include: